Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 290.69 | N/A |
| PEG Ratio (TTM) | 3.32 | N/A |
| P/S Ratio (TTM) | 1.95 | N/A |
| P/B Ratio (TTM) | 3.32 | N/A |
| P/FCF Ratio (TTM) | 5.59 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.61% | N/A |
| ROE (TTM) | 1.19% | N/A |
| Net Profit Margin (TTM) | 0.65% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.28% | 36.41% | N/A |
| Revenue | 5.31% | 82.04% | N/A |
| Net Income | 5.48% | -88.14% | N/A |
| Cash Flow | 16.27% | -45.75% | N/A |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.49 | N/A |
| Quick Ratio (TTM) | 5.81 | N/A |
| D/E Ratio (TTM) | 0.61 | N/A |
| Interest Coverage (TTM) | 0.73 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.31 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |